A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease

PURPOSE: The purpose of the study was to evaluate, as a pilot trial, safety and tolerability of CAM-101 10% and 30% topical ophthalmic fibrinogen-depleted human platelet lysate (FD hPL) solution in patients with dry eye disease (DED) secondary to graft-versus-host disease (GvHD) after 6 weeks of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugar, Alan, Hussain, Munira, Chamberlain, Winston, Dana, Reza, Kelly, David Patrick, Ta, Christopher, Irvine, John, Daluvoy, Melissa, Perez, Victor, Olson, Joshua, Jhanji, Vishal, Walts, Terence A., Stulting, Robert Doyle, Waller, Edmund K., Jagirdar, Neera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562362/
https://www.ncbi.nlm.nih.gov/pubmed/36245754
http://dx.doi.org/10.1016/j.xops.2022.100176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562362/
https://www.ncbi.nlm.nih.gov/pubmed/36245754
http://dx.doi.org/10.1016/j.xops.2022.100176

Ejemplares similares